You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

299 Results
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    lorlatinib - For the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer.
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
lorlatinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Feb 2025
The cervical screening test checks for types of human papillomavirus (HPV) that can sometimes cause cervical cancer. It also checks for cell changes...
Santé Ontario (Action Cancer Ontario) envoie des lettres aux personnes âgées de 25 à 74 ans ayant un col de l’utérus pour les inviter à effectuer un...
A wide range of cancer screening, diagnostic and treatment services is available at cancer centres, hospitals and clinics throughout Ontario. Some of...
Drug
Other Name(s): Neupogen®, Grastofil®, Nivestym®, Nypozi®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Updated
Apr 2025
Document
New
Apr 2025
Guidelines and Advice
Status: In-Review
ID: RR SCT-9
Version: N/A
Jun 2020

Pages